tetradecanoylphorbol acetate and Peripheral Vascular Diseases

tetradecanoylphorbol acetate has been researched along with Peripheral Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chin-Dusting, JP; Murphy, AJ; Shaw, J; Stirzaker, RA; Suhartoyo, A; Sviridov, D; Woollard, KJ	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Peripheral Vascular Diseases

Article	Year
Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation. Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:6 Topics: Animals; Apolipoprotein A-I; CD11b Antigen; Cell Adhesion; Cell Movement; Cholesterol; Humans; Inflammation; Lipoproteins, HDL; Male; Membrane Microdomains; Mice; Mice, Inbred C57BL; Neutrophil Activation; Peripheral Vascular Diseases; Scavenger Receptors, Class B; Tetradecanoylphorbol Acetate	2011

Article

Year

Neutrophil activation is attenuated by high-density lipoprotein and apolipoprotein A-I in in vitro and in vivo models of inflammation.

Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:6

Topics: Animals; Apolipoprotein A-I; CD11b Antigen; Cell Adhesion; Cell Movement; Cholesterol; Humans; Inflammation; Lipoproteins, HDL; Male; Membrane Microdomains; Mice; Mice, Inbred C57BL; Neutrophil Activation; Peripheral Vascular Diseases; Scavenger Receptors, Class B; Tetradecanoylphorbol Acetate

2011